A phase II study to determine the efficacy and tolerability of intravenous ZD9331 in heavily pretreated patients with ovarian cancer

J. S. Rader, D. Clarke-Pearson, M. Moore, Linda F Carson, R. Holloway, M. S. Kao, I. Wiznitzer, E. C. Douglass

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint Dive into the research topics of 'A phase II study to determine the efficacy and tolerability of intravenous ZD9331 in heavily pretreated patients with ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences